182 related articles for article (PubMed ID: 32564942)
1. Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review.
Morin J; Peard L; Vanadurongvan T; Walker J; Dönmez Mİ; Saltzman AF
J Pediatr Urol; 2020 Oct; 16(5):576-582. PubMed ID: 32564942
[TBL] [Abstract][Full Text] [Related]
2. Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery - A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology.
Peard LM; Morin J; Flores V; Graham K; Taylor AS; Pope JC; Halstead V; Cost NG; Roberts EM; Makari JH; Cranford W; Saltzman AF
J Pediatr Urol; 2023 Aug; 19(4):399.e1-399.e8. PubMed ID: 37117082
[TBL] [Abstract][Full Text] [Related]
3. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
[TBL] [Abstract][Full Text] [Related]
4. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
[TBL] [Abstract][Full Text] [Related]
5. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
Pyle LC; Nathanson KL
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
[TBL] [Abstract][Full Text] [Related]
6. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
[TBL] [Abstract][Full Text] [Related]
8. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence.
Huang H; Wang C; Tian Q
Clin Endocrinol (Oxf); 2017 Apr; 86(4):621-627. PubMed ID: 27862157
[TBL] [Abstract][Full Text] [Related]
9. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
10. Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ.
Dieckmann KP; Tribius S; Angerer M; Salzbrunn A; von Kopylow K; Mollenhauer M; Wülfing C
Strahlenther Onkol; 2023 Mar; 199(3):322-326. PubMed ID: 36441172
[TBL] [Abstract][Full Text] [Related]
11. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
[TBL] [Abstract][Full Text] [Related]
12. Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study.
Dicken BJ; Billmire DF; Krailo M; Xia C; Shaikh F; Cullen JW; Olson TA; Pashankar F; Malogolowkin MH; Amatruda JF; Rescorla FJ; Egler RA; Ross JH; Rodriguez-Galindo C; Frazier AL
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286555
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, distribution, and risk markers for the development of gonadal germ cell tumors in patients with certain types of disorders of sexual differentiation with Y chromosome - A retrospective study.
Das DV; Jabbar PK; Gomez R; Nambisan B; Bhuvitha MS; Nair A; Jayakumari C
Indian J Cancer; 2023 Oct; 60(4):464-474. PubMed ID: 38078466
[TBL] [Abstract][Full Text] [Related]
14. Management and outcome of paediatric testicular tumours - A 20 year experience.
O'Shea K; Tong A; Farrelly P; Craigie R; Cheesman E; Shukla R; Losty P
J Pediatr Surg; 2021 Nov; 56(11):2032-2036. PubMed ID: 33789803
[TBL] [Abstract][Full Text] [Related]
15. Disorder of sex development with germ cell tumors: Which is uncovered first?
Faure-Conter C; Orbach D; Fresneau B; Verité C; Bonneau J; Thebaud E; Poirée M; Thouvenin S; Pluchart C; Mure PY; Dijoud F; Morel Y
Pediatr Blood Cancer; 2020 Apr; 67(4):e28169. PubMed ID: 32020769
[TBL] [Abstract][Full Text] [Related]
16. [Gonadal neoplastic related lesions in children with disorders of sexual development: a clinicopathological study of twelve cases].
Niu HL; Yi P; Gao Q; Wang FH; Chen ZR; Li LP; Xia JQ; Cao Y; Zeng RX
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1145-1150. PubMed ID: 34619868
[No Abstract] [Full Text] [Related]
17. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
18. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
19. Malignant germ cell tumors in men aged 50 years and over are associated with adverse pathologic features and higher stage at presentation.
Almutairi F; Geisler D; Rammal R; Korentzelos D; Bastacky S; Dhir R; Bhattu A; Quiroga-Garza GM
Ann Diagn Pathol; 2023 Feb; 62():152070. PubMed ID: 36495736
[TBL] [Abstract][Full Text] [Related]
20. The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.
Camacho-Moll ME; Macdonald J; Looijenga LHJ; Rimmer MP; Donat R; Marwick JA; Shukla CJ; Carragher N; Jørgensen A; Mitchell RT
BMC Cancer; 2019 Nov; 19(1):1124. PubMed ID: 31744479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
